Earnings Call · Q1 FY2022·2022-05-09

Q1 22EPS +67.16%·Rev n/aQ4 21EPS +47.67%·Rev n/aQ3 21EPS +19.18%·Rev n/aQ2 21EPS -10.47%·Rev n/a⚠ consensus missing

ADC Therapeutics SA ADCT

Amanda Hamilton — Investor Relations

Chris Martin — Former Chief Executive Officer

Ameet Mallik — Chief Executive Officer

Jennifer Herron — Chief Commercial Officer

Joe Camardo — Chief Medical Officer

Jenn Creel — Chief Financial Officer

−28.7%1d on move date−25.5% vs SPY3d−36.7%5d−32.5%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADCT calls or request research access.

More ADCT calls Browse calls Request research access